Related Experiment Video
Updated: Jul 14, 2026

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
Published on: December 28, 2019
Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB
Jun Yasuda1, Hideki Yokoo, Tesshi Yamada
1Cancer Transcriptome Project, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan. jyasuda@ncc.go.jp
Abstract:
Nemo-like kinase (NLK) is a serine/threonine kinase that suppresses the transcription activity of the beta-catenin-T-cell factor (TCF) complex through phosphorylation of TCF. Our previous study showed that NLK overexpression induces apoptosis in DLD-1 human colon cancer cells and that apoptosis induction presumably requires a mechanism other than the suppression of beta-catenin-TCF complex. Luciferase reporter gene assay with pNF-kappaB-Luc revealed that NLK could suppress transcription activity of NF-kappaB in a kinase-dependent manner. However, it appeared that transcription co-activators of NF-kappaB, such as CREB binding protein (CBP)/p300, were likely to be the direct targets of NLK, rather than NF-kappaB itself. Luciferase reporter gene analysis of GAL4-CBP fusion proteins revealed that the C-terminal region of CBP was critical for transcription suppression by NLK. In vitro kinase assay showed that NLK could phosphorylate the C-terminal domain of CBP. However, HAT activity was not suppressed by the induction of wild-type NLK in DLD-1 cells. Furthermore, we observed that NLK suppressed the transcription activity of AP-1, Smad, and p53, all of which also utilize CBP as a co-activator. The extent of suppression by NLK was similar among the transcription factors tested (50-60% reduction). Our results suggest that NLK may suppress a wide range of gene expression, possibly through CBP.
Insights
Nemo-like kinase (NLK) suppresses gene transcription by targeting co-activators like CREB binding protein (CBP). This kinase activity impacts multiple transcription factors, suggesting a broad role in gene regulation beyond beta-catenin signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Nemo-like kinase (NLK) is a serine/threonine kinase.
- NLK phosphorylates TCF, suppressing beta-catenin-TCF complex activity.
- Previous studies linked NLK overexpression to apoptosis in colon cancer cells.
Purpose of the Study:
- To investigate the mechanism by which NLK suppresses transcription.
- To determine if NLK directly targets NF-kappaB or its co-activators.
- To explore NLK's broader role in regulating transcription factors.
Main Methods:
- Luciferase reporter gene assays (pNF-kappaB-Luc, GAL4-CBP fusion proteins).
- In vitro kinase assays to assess NLK phosphorylation of CBP.
- Analysis of NLK's effect on transcription factors AP-1, Smad, and p53.
Main Results:
- NLK suppresses NF-kappaB transcription activity in a kinase-dependent manner.
- NLK directly phosphorylates the C-terminal region of CBP/p300.
- NLK suppresses transcription activity of AP-1, Smad, and p53, which use CBP as a co-activator.
Conclusions:
- NLK's kinase activity targets transcription co-activators like CBP.
- NLK broadly suppresses gene expression by interacting with CBP.
- NLK may regulate diverse cellular processes through CBP-mediated pathways.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
Master Transcription Regulators

